Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| HSIC | NASDAQ | Henry Schein, Inc. | $88.36 | +1.21% | 714K | $10.07B |
| PTGX | NASDAQ | Protagonist Therapeutics, Inc. | $148.18 | +2.08% | 478K | $9.53B |
| KYMR | NASDAQ | Kymera Therapeutics, Inc. | $114.96 | -1.74% | 574K | $9.46B |
| PRAX | NASDAQ | Praxis Precision Medicines, Inc. | $334.58 | -1.18% | 174K | $9.33B |
| RGEN | NASDAQ | Repligen Corporation | $165.18 | +0.30% | 943K | $9.32B |
| CYTK | NASDAQ | Cytokinetics, Incorporated | $73.77 | +0.20% | 1.7M | $9.18B |
| PODD | NASDAQ | Insulet Corp. | $131.96 | -2.02% | 1.7M | $9.14B |
| IONS | NASDAQ | Ionis Pharmaceuticals, Inc. | $54.21 | -2.59% | 2.2M | $9.01B |
| ABVX | NASDAQ | Abivax S.A. | $118.64 | +2.32% | 893K | $8.71B |
| TXG | NASDAQ | 10x Genomics, Inc. | $68.59 | +3.33% | 1.8M | $8.71B |
| PCVX | NASDAQ | Vaxcyte, Inc. | $59.47 | +0.97% | 1.7M | $8.59B |
| APGE | NASDAQ | Apogee Therapeutics, Inc. | $135.07 | 0.00% | 0 | $8.36B |
| IBRX | NASDAQ | ImmunityBio, Inc. | $7.91 | +2.46% | 12.4M | $8.28B |
| TGTX | NASDAQ | TG Therapeutics, Inc. | $53.89 | -2.71% | 1.4M | $8.25B |
| BRKR | NASDAQ | Bruker Corporation | $53.43 | -0.24% | 2.1M | $8.13B |
| HQY | NASDAQ | HealthEquity, Inc. | $96.26 | +1.81% | 652K | $8.05B |
| BRKRP | NASDAQ | Bruker Corporation | $399.57 | +1.12% | 1K | $8.02B |
| TWST | NASDAQ | Twist Bioscience Corporation | $127.22 | +0.29% | 1.1M | $7.92B |
| SYRE | NASDAQ | Spyre Therapeutics, Inc. | $90.60 | +2.13% | 886K | $7.87B |
| ALKS | NASDAQ | Alkermes plc | $45.97 | -0.30% | 1.2M | $7.71B |
| IMVT | NASDAQ | Immunovant, Inc. | $37.36 | -1.94% | 1M | $7.71B |
| RYTM | NASDAQ | Rhythm Pharmaceuticals, Inc. | $104.71 | +2.46% | 574K | $7.18B |
| BLTE | NASDAQ | Belite Bio, Inc | $173.79 | -0.73% | 144K | $6.97B |
| CAI | NASDAQ | Caris Life Sciences, Inc. | $24.34 | +1.25% | 1.8M | $6.88B |
| SRRK | NASDAQ | Scholar Rock Holding Corporation | $55.41 | -0.47% | 922K | $6.64B |
| LNTH | NASDAQ | Lantheus Holdings, Inc. | $100.25 | -0.14% | 1.2M | $6.53B |
| GRFS | NASDAQ | Grifols, S.A. | $7.55 | -1.31% | 513K | $6.39B |
| CGON | NASDAQ | CG Oncology Inc. | $72.35 | +0.49% | 760K | $6.38B |
| MMED | NASDAQ | MiniMed Group, Inc. Common Stock | $22.50 | +0.27% | 1.4M | $6.32B |
| TVTX | NASDAQ | Travere Therapeutics, Inc. | $66.17 | -1.98% | 1.1M | $6.15B |
| MIRM | NASDAQ | Mirum Pharmaceuticals, Inc. | $98.22 | -2.38% | 441K | $5.99B |
| DNTH | NASDAQ | Dianthus Therapeutics, Inc. | $106.20 | +2.83% | 733K | $5.94B |
| RDNT | NASDAQ | RadNet, Inc. | $75.49 | +1.63% | 610K | $5.94B |
| LQDA | NASDAQ | Liquidia Corporation | $66.74 | -1.64% | 778K | $5.94B |
| KNSA | NASDAQ | Kiniksa Pharmaceuticals International, plc | $76.27 | -0.27% | 358K | $5.81B |
| COGT | NASDAQ | Cogent Biosciences, Inc. | $33.41 | -1.97% | 1.7M | $5.71B |
| LGND | NASDAQ | Ligand Pharmaceuticals Incorporated | $284.47 | -1.65% | 261K | $5.7B |
| XENE | NASDAQ | Xenon Pharmaceuticals Inc. | $58.65 | -0.26% | 467K | $5.67B |
| ORKA | NASDAQ | Oruka Therapeutics, Inc. | $92.38 | +0.80% | 585K | $5.57B |
| PTCT | NASDAQ | PTC Therapeutics, Inc. | $66.06 | -1.94% | 793K | $5.51B |
| ERAS | NASDAQ | Erasca, Inc. | $15.88 | -0.94% | 2.9M | $5.51B |
| AMRX | NASDAQ | Amneal Pharmaceuticals, Inc. | $17.01 | +0.83% | 1.1M | $5.43B |
| SHC | NASDAQ | Sotera Health Company | $18.37 | +0.60% | 1.3M | $5.24B |
| DFTX | NASDAQ | Definium Therapeutics, Inc. | $38.89 | +3.07% | 1.4M | $5.16B |
| MMSI | NASDAQ | Merit Medical Systems, Inc. | $86.36 | -0.13% | 441K | $5.16B |
| LFST | NASDAQ | LifeStance Health Group, Inc. | $12.97 | -0.23% | 7.1M | $5.03B |
| CRSP | NASDAQ | CRISPR Therapeutics AG | $51.72 | -1.03% | 855K | $4.99B |
| EWTX | NASDAQ | Edgewise Therapeutics, Inc. | $44.40 | +3.50% | 1.3M | $4.78B |
| ACAD | NASDAQ | ACADIA Pharmaceuticals Inc. | $27.83 | +0.32% | 1.2M | $4.77B |
| BLLN | NASDAQ | BillionToOne, Inc. | $98.77 | +0.26% | 406K | $4.54B |
50 Healthcare Companies
Review companies currently returned for the Healthcare screen, with price, performance, volume and market-cap context.
How This Sector Screen Works
Results are loaded from current company data and can be narrowed by exchange or company search without changing the canonical sector page.
About the Healthcare Sector
The Healthcare classification groups companies with related business activities so investors can compare peers within a common market segment.
Related Sector Screens
Return to the screener directory to compare this sector with daily movers and the other industry groups covered by Cashu Finance.